Medicare Enrolled
Dr. Jason Zagrodzky, M.D.
Cardiovascular Disease · Austin, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zagrodzky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zagrodzky? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zagrodzky
Dr. Jason Zagrodzky is a cardiovascular disease in Austin, TX, with 20 years in practice. Based on federal Medicare data, Dr. Zagrodzky performed 5,140 Medicare services across 3,210 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zagrodzky received a total of $903,022 from 29 pharmaceutical and/or device companies across 1327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zagrodzky is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 16% volume in TX$ $903,022 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,140
Medicare services
Top 16% in TX for cardiovascular disease
3,210
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~257 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead | 952 | $11 | $58 |
| Remote pacemaker/defibrillator monitoring, 90 days | 683 | $17 | $98 |
| Office visit, established patient (30-39 min) | 587 | $95 | $223 |
| Remote pacemaker monitoring, 90 days | 365 | $22 | $106 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 321 | $26 | $207 |
| Office visit, established patient (20-29 min) | 216 | $67 | $147 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 172 | $28 | $144 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 171 | $19 | $85 |
| New patient office visit (45-59 min) | 171 | $122 | $350 |
| Programming of heart rhythm stimulation after drug infusion | 146 | $66 | $583 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 144 | $238 | $1,229 |
| Programming of dual lead pacemaker system | 140 | $57 | $177 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 107 | $725 | $3,280 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 99 | $132 | $595 |
| Telephone medical discussion with physician, 11-20 minutes | 97 | $73 | $152 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 80 | $237 | $1,230 |
| Office visit, established patient, complex (40-54 min) | 59 | $126 | $312 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 58 | $59 | $866 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 56 | $654 | $2,457 |
| Programming of multiple lead implantable defibrillator system | 47 | $76 | $281 |
| Programming of dual lead implantable defibrillator system | 45 | $77 | $250 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 34 | $367 | $1,699 |
| Evaluation of implantable heart and blood vessel monitoring system | 34 | $36 | $89 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $87 | $200 |
| External shock to heart to regulate heart beat | 27 | $84 | $390 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 27 | $16 | $72 |
| Insertion of tube in left heart chamber through heart septum | 27 | $162 | $626 |
| Programming of multiple lead pacemaker system | 25 | $62 | $206 |
| New patient office visit, complex (60-74 min) | 22 | $169 | $455 |
| Repair of left upper heart chamber with implant with review by radiologist | 19 | $525 | $2,519 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 18 | $362 | $1,482 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 18 | $10 | $45 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 18 | $16 | $79 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 18 | $121 | $1,381 |
| Heart rhythm recording of continous external ekg over 8-15 days | 17 | $10 | $45 |
| Initial hospital admission, moderate complexity | 17 | $104 | $268 |
| New patient office visit (30-44 min) | 16 | $85 | $215 |
| Insertion of implantable defibrillator system | 15 | $722 | $2,943 |
| Evaluation of cardiac rhythm monitor system | 15 | $40 | $112 |
| Initial hospital admission, high complexity | 15 | $140 | $393 |
| Destruction of heart conduction tissue to create heart block | 13 | $456 | $1,901 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.0% high complexity
1.1% medium
54.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$903,022
Total received (2018-2024)
Avg $129,003/year across 7 years
Top 0% in TX for cardiovascular disease
29
Companies
1,327
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$502,144 (55.6%)
Other
Charitable contributions, space rental, and other categories
$330,443 (36.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47,711 (5.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,724 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$395,742
2023$86,077
2022$103,078
2021$67,583
2020$110,625
2019$89,352
2018$50,565
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Haemonetics Corporation
$330,443
Medical Device Business Services, Inc.
$288,020
Biosense Webster, Inc.
$200,931
SANOFI-AVENTIS U.S. LLC
$26,325
Abbott Laboratories
$25,717
Janssen Pharmaceuticals, Inc
$19,457
Medtronic, Inc.
$3,224
ATRICURE, INC.
$1,913
PFIZER INC.
$1,689
Boston Scientific Corporation
$1,165
CVRx, Inc.
$877
E.R. Squibb & Sons, L.L.C.
$673
Medtronic Vascular, Inc.
$544
CARDIVA MEDICAL, INC.
$436
Impulse Dynamics (USA) Inc.
$372
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$318
AtriCure, Inc.
$313
OPTOS, INC.
$147
iRhythm Technologies, Inc.
$139
BOSTON SCIENTIFIC CORPORATION
$77
Johnson & Johnson Health Care Systems Inc.
$68
Baxter Healthcare
$48
BIOTRONIK INC.
$28
Becton, Dickinson and Company
$21
ConvaTec Inc.
$19
Merck Sharp & Dohme LLC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Bardy Diagnostics, Inc.
$15
Aziyo Biologics, Inc.
$9
Top 3 companies account for 90.7% of total payments
Associated products mentioned in payments ›
ALLURE QUADRA · AMPLIA MRI QUAD CRT-D SURESCAN · AQUACEL Ag Advantage Surgical · ARCTIC FRONT ADVANCE · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) · AVEIR · AZURE XT DR MRI SURESCAN · Ablation Therapy Hardware · Absolute Pro vascular stent system · Accent Pacemaker · Advisa · Advisor Catheter · Agilis NxT EP Introducer · Allure CRT Pacemaker · Allure Quadra RF CRT Pacemaker · Amplia MRI · Assurity Pacemaker · AtriCure Synergy Ablation System · Attain · Azure · BELSOMRA · Barostim Neo System · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · CRT-Ds · CRT-Ps · Cardiac Mapping System · CareLink · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Carto Smarttouch · CartoSound · Claria MRI · Cobalt · Confirm Rx · Crome · CryoConsole · Durata Defibrillation ICD Lead · ECM · ELIQUIS · ENSITE · ENSITE PRECISION · ENSOETM · EP-Research Only · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVERA MRI XT DR SURESCAN · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FORTIFY ASSURA · Fortify Assura · GALLANT · GENERAL THERAPIES · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL THERAPIES · HemoSphere · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · JARDIANCE · LATITUDE CLARITY · LINQ II · LUX-DX · LifeVest · MICRA · MULTAQ · Micra · Monaco · NA · NUVISION ICE CATHETER · OCTARAY MAPPING CATHETER · OPTIMIZER · Omnilink Elite vascular stent system · Optimizer Smart System · PENTARAY · PERCLOSE PROGLIDE · PERCLOSE PROSTYLE · Pentaray · Pentaray Nav · Perclose ProGlide suture mediated closure system · QDOT MICRO Catheter · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE · Reveal LINQ · SELECTSECURE · SENSOR ENABLED · SYNERGY ABLATION SYSTEM · Smartablate · Soundstar · SureScan · TACTICATH ABLATION CATHETER · THERMOCOOL SMARTTOUCH · TactiCath Quartz CFA Catheter · VISITAG SURPOINT External Processing Unit · VYNDAQEL · ViewMate Intracardiac Echo · Visitag · WATCHMAN · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for cardiovascular disease in TX.
Equivalent to $17,569 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
86
Per 100K population
6.6
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Zagrodzky is a electrophysiology & remote specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (consulting-driven, top 0%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Zagrodzky experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Zagrodzky performed 952 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zagrodzky receive payments from pharmaceutical companies?
Yes. Dr. Zagrodzky received a total of $903,022 from 29 companies across 1,327 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zagrodzky's costs compare to other cardiovascular diseases in Austin?
Dr. Zagrodzky's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zagrodzky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Austin
Browse cardiovascular diseases in Austin ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Haemonetics Corporation Payments to Doctors
See all physicians who received payments from Haemonetics Corporation.
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc..
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology